Quest Diagnostics
DGX
#1119
Rank
โ‚น2.023 T
Marketcap
โ‚น18,281
Share price
-0.79%
Change (1 day)
22.52%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2025 (TTM): โ‚น775.58

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น841.59. In 2024 the company made an earnings per share (EPS) of โ‚น738.17 an increase over its 2023 EPS that were of โ‚น720.14.

EPS history for Quest Diagnostics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น775.585.07%
2024โ‚น738.172.5%
2023โ‚น720.14-5.83%
2022โ‚น764.73-49.21%
2021โ‚น1,50649.72%
2020โ‚น1,00666.67%
2019โ‚น603.4418%
2018โ‚น511.40-4.26%
2017โ‚น534.1723.19%
2016โ‚น433.60-7.11%
2015โ‚น466.8128.46%
2014โ‚น363.39-31.61%
2013โ‚น531.3360.46%
2012โ‚น331.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น999.09 18.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น67.53-108.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น79.70-109.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น195.46-76.77%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น19.92-102.37%๐Ÿ‡บ๐Ÿ‡ธ USA